The PNPLA3 rs738409 C > G polymorphism is associated with the risk of progression to cirrhosis in NAFLD patients
- PMID: 27150500
- DOI: 10.3109/00365521.2016.1161066
The PNPLA3 rs738409 C > G polymorphism is associated with the risk of progression to cirrhosis in NAFLD patients
Abstract
Background and aims: The patatin-like phospholipase domain-containing 3 (PNPLA3) rs738409 C > G single nucleotide polymorphism (SNP) has been associated with steatosis and fibrosis in previous NAFLD populations in which cirrhotic patients were very poorly represented. Since not all NAFLD with fibrosis evolve to cirrhosis, we investigated the specific risk of cirrhosis conferred in NAFLD patients by carrying this SNP.
Methods: Three groups were studied: patients with NASH-cirrhosis; patients with biopsy-proven non-cirrhotic NAFLD; healthy subjects undergoing medicine check-ups. Epidemiological, anthropometric, and clinical data were collected, and the SNP was analyzed by pyrosequencing.
Results: Sixty-one patients with NASH-cirrhosis, 60 with non-cirrhotic NAFLD, and 125 healthy controls were included. Frequency of the PNPLA3 minor (G) allele was increased in patients with NASH-cirrhosis compared with non-cirrhotic NAFLD and controls (allele frequency: 0.598 versus 0.367 versus 0.2, respectively, p < 0.001), and different between the latter two groups (p < 0.001). Three-quarters (74%) of NASH cirrhotics carried at least one G allele, and almost half of them (46%) were GG homozygous. By multivariate analysis in the NAFLD population, each copy of the G allele was associated with an almost doubling of the risk of cirrhosis [OR 1.8 (1.02-3.2)], while being GG homozygous with a tripled risk compared with being CC homozygous [3.01 (1.03-10.8)].
Conclusions: In NAFLD patients, carriage of the PNPLA3G allele, and particularly of the GG genotype, is significantly associated with the risk of cirrhotic evolution. If confirmed in larger series, these results would suggest that most of NASH cases require the contribution of an altered PNPLA3 function to progress until cirrhosis.
Keywords: NASH cirrhosis; Non-alcoholic fatty liver disease; patatin-like phospholipase domain-containing 3.
Similar articles
-
Association of single nucleotide polymorphism at PNPLA3 with fatty liver, steatohepatitis, and cirrhosis of liver.Indian J Gastroenterol. 2017 Sep;36(5):366-372. doi: 10.1007/s12664-017-0784-y. Epub 2017 Oct 4. Indian J Gastroenterol. 2017. PMID: 28975533
-
Validation of PNPLA3 polymorphisms as risk factor for NAFLD and liver fibrosis in an admixed population.Ann Hepatol. 2019 May-Jun;18(3):466-471. doi: 10.1016/j.aohep.2018.10.004. Epub 2019 Apr 18. Ann Hepatol. 2019. PMID: 31054980
-
Carriage of the PNPLA3 rs738409 C >G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma.J Hepatol. 2014 Jul;61(1):75-81. doi: 10.1016/j.jhep.2014.02.030. Epub 2014 Mar 6. J Hepatol. 2014. PMID: 24607626
-
Association between patatin-like phospholipase domain containing 3 gene (PNPLA3) polymorphisms and nonalcoholic fatty liver disease: a HuGE review and meta-analysis.Sci Rep. 2015 Mar 20;5:9284. doi: 10.1038/srep09284. Sci Rep. 2015. PMID: 25791171 Free PMC article. Review.
-
Association between rs738409 polymorphism in patatin-like phospholipase domain-containing protein 3 (PNPLA3) gene and hepatocellular carcinoma susceptibility: Evidence from case-control studies.Gene. 2019 Feb 15;685:143-148. doi: 10.1016/j.gene.2018.11.012. Epub 2018 Nov 4. Gene. 2019. PMID: 30403964 Review.
Cited by
-
PNPLA3 Polymorphism Is Inversely Correlated with Aortic Stiffness in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease Without Fibrosis.Int J Mol Sci. 2025 Apr 1;26(7):3256. doi: 10.3390/ijms26073256. Int J Mol Sci. 2025. PMID: 40244110 Free PMC article.
-
Genetic Predictors of Comorbid Course of COVID-19 and MAFLD: A Comprehensive Analysis.Viruses. 2023 Aug 12;15(8):1724. doi: 10.3390/v15081724. Viruses. 2023. PMID: 37632067 Free PMC article. Review.
-
Association between PNPLA3 rs738409 polymorphism and nonalcoholic fatty liver disease: a systematic review and meta-analysis.BMC Endocr Disord. 2021 Jun 19;21(1):125. doi: 10.1186/s12902-021-00789-4. BMC Endocr Disord. 2021. PMID: 34147109 Free PMC article.
-
Promoting genetics in non-alcoholic fatty liver disease: Combined risk score through polymorphisms and clinical variables.World J Gastroenterol. 2018 Nov 21;24(43):4835-4845. doi: 10.3748/wjg.v24.i43.4835. World J Gastroenterol. 2018. PMID: 30487694 Free PMC article.
-
Metabolic-Associated Steatotic Liver Disease (MASLD): A New Term for a More Appropriate Therapy in Pediatrics?Pediatr Rep. 2024 Apr 10;16(2):288-299. doi: 10.3390/pediatric16020025. Pediatr Rep. 2024. PMID: 38651464 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical